Parnell Pharmaceuticals Holdings Ltd
OTC:PARNF
Balance Sheet
Balance Sheet Decomposition
Parnell Pharmaceuticals Holdings Ltd
Parnell Pharmaceuticals Holdings Ltd
Balance Sheet
Parnell Pharmaceuticals Holdings Ltd
| Dec-2014 | Dec-2015 | ||
|---|---|---|---|
| Assets | |||
| Cash & Cash Equivalents |
16
|
6
|
|
| Cash |
16
|
6
|
|
| Total Receivables |
5
|
7
|
|
| Accounts Receivables |
2
|
7
|
|
| Other Receivables |
3
|
0
|
|
| Inventory |
3
|
3
|
|
| Other Current Assets |
0
|
1
|
|
| Total Current Assets |
24
|
17
|
|
| PP&E Net |
12
|
13
|
|
| PP&E Gross |
12
|
0
|
|
| Accumulated Depreciation |
4
|
0
|
|
| Intangible Assets |
12
|
17
|
|
| Note Receivable |
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
|
| Total Assets |
48
N/A
|
46
-4%
|
|
| Liabilities | |||
| Accounts Payable |
4
|
7
|
|
| Accrued Liabilities |
2
|
0
|
|
| Short-Term Debt |
0
|
0
|
|
| Current Portion of Long-Term Debt |
5
|
3
|
|
| Other Current Liabilities |
3
|
0
|
|
| Total Current Liabilities |
14
|
10
|
|
| Long-Term Debt |
0
|
14
|
|
| Deferred Income Tax |
0
|
0
|
|
| Other Liabilities |
1
|
1
|
|
| Total Liabilities |
14
N/A
|
26
+81%
|
|
| Equity | |||
| Common Stock |
55
|
55
|
|
| Retained Earnings |
20
|
32
|
|
| Other Equity |
2
|
3
|
|
| Total Equity |
34
N/A
|
20
-40%
|
|
| Total Liabilities & Equity |
48
N/A
|
46
-4%
|
|
| Shares Outstanding | |||
| Common Shares Outstanding |
13
|
13
|
|